glp-1 news today nov 2025 ISPOR 2025: Exploring reasons for discontinuation GLP-1 Receptor Agonist Market Growth
Description
If youre looking into GLP-1 medications for weight loss, youve probably come across two big names: semaglutide and tirzepatide. So whats the difference
Its mission: to help everyone understand our complicated world, so that we can all help shape it
Supports metabolic efficiency and energy balance research
Flier, for being an important part of the early discovery work, almost four decades ago.
The pharmacy benefit manager announced it will cover Lillys Foundayo starting June 1 and Zepbound starting in October, a setback of sorts for rival Novo Nordisk as Wegovy has been preferred.
